The influence of Javanese turmeric (Curcuma xanthorrhiza) on the pharmacokinetics of warfarin in rats with single and multiple-dose studies

References

• Ansell J, McDonough M, Zhao Y, Harmatz JS, Greenblatt DJ. 2009. The absence of an interaction between warfarin and cranberry juice: a randomized, double-blind trial. J Clin Pharmacol. 49(7):824–830.
   PubMed Web of Science ®Google Scholar
• Bachmann K, Shapiro R, Fulton R, Carroll FT, Sullivan TJ. 1979. Smoking and warfarin disposition. Clin Pharmacol Ther. 25:309–315.
   PubMed Web of Science ®Google Scholar
• Bernaitis N, Ching CK, Chen L, Hon JS, Teo SC, Davey AK, Anoopkumar-Dukie S. 2017. The sex, age, medical history, treatment, tobacco use, race risk (SAMe TT2R2) score predicts warfarin control in a Singaporean population. J Stroke Cerebrovasc Dis. 26(1):64–69.
   PubMed Web of Science ®Google Scholar
• Black DJ, Kunze KL, Wienkers LC, Gidal BE, Seaton TL, McDonnell ND, Evans JS, Bauwens JE, Trager WF. 1996. Warfarin-fluconazole. II. A metabolically based drug interaction: in vivo studies. Drug Metab Dispos. 24:422–428.
   PubMed Web of Science ®Google Scholar
• Cheng TO. 2007. Green tea may inhibit warfarin. Int J Cardiol. 115:236.
   PubMed Web of Science ®Google Scholar
• Custodio das Dores SM, Booth SL, Martini LA, de Carvalho Gouvea VH, Padovani CR, de Abreu Maffei FH, Campana AO, Rupp de Paiva SA. 2007. Relationship between diet and anticoagulant response to warfarin: a factor analysis. Eur J Nutr. 46:147–154.
   PubMed Web of Science ®Google Scholar
• Gericke KR. 1993. Possible interaction between warfarin and fluconazole. Pharmacotherapy. 13:508–509.
   PubMed Web of Science ®Google Scholar
• Guo C, Xue S, Zheng X, Lu Y, Zhao D, Chen X, Li N. 2018. The effect of fenofibric acid on the pharmacokinetics and pharmacodynamics of warfarin in rats. Xenobiotica. 48:400–406.
   PubMed Web of Science ®Google Scholar
• Haffa A, Krueger D, Bruner J, Engelke J, Gundberg C, Akhter M, Binkley N. 2010. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. J Bone Miner Res. 15(5):872–878.
   Google Scholar
• Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D. 2001. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 119(1 Suppl):8S–21S.
   PubMed Web of Science ®Google Scholar
• Ikatan Apoteker Indonesia (IAI). 2017. ISO informasi Spesialite Obat Indonesia. Vol. 51. Jakarta: ISFI Penerbitan.
   Google Scholar
• Ismail HF, Hashim Z, Soon WT, Rahman NSA, Zainudin AN, Majid FAA. 2017. Comparative study of herbal plants on the phenolic and flavonoid content, antioxidant activities and toxicity on cells and zebrafish embryo. J Tradit Complement Med. 7:452–465.
   PubMedGoogle Scholar
• Itokawa H, Shi Q, Akiyama T, Morris-Natschke SL, Lee KH. 2008. Recent advances in the investigation of curcuminoids. Chin Med. 3:11.
   PubMedGoogle Scholar
• Kaminsky LS, Zhang ZY. 1997. Human P450 metabolism of warfarin. Pharmacol Therap. 73(1):67–74.
   PubMed Web of Science ®Google Scholar
• Kato Y, Ichida F, Saito K, Watanabe K, Hirono K, Miyawaki T, Yoshimura N, Horiuchi I, Taguchi M, Hashimoto Y. 2011. Effect of the VKORC1 genotype on warfarin dose requirements in Japanese pediatric patients. Drug Metab Pharmacokinet. 26:295–299.
   PubMed Web of Science ®Google Scholar
• Khoury G, Sheikh-Taha M. 2014. Effect of age and sex on warfarin dosing. Clin Pharmacol. 6:103–106.
   PubMedGoogle Scholar
• Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD. 1995. Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol. 35:1008–1015.
   PubMed Web of Science ®Google Scholar
• Kunze KL, Wienkers LC, Thummel KE, Trager WF. 1996. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies. Drug Metab Dispos. 24:414–421.
   PubMed Web of Science ®Google Scholar
• Lagishetty CV, Deng J, Lesko LJ, Rogers H, Pacanowski M, Schmidt S. 2016. How informative are drug-drug interactions of gene-drug interactions? J Clin Pharmacol. 56:1221–1231.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang C, Fan R, Sun H, Xie H, Luo J, Wang Y, Lv H, Tang T. 2016. The effects of Chuanxiong on the pharmacokinetics of warfarin in rats after biliary drainage. J Ethnopharmacol. 193:117–124.
   PubMed Web of Science ®Google Scholar
• Makino T, Wakushima H, Okamoto T, Okukubo Y, Deguchi Y, Kano Y. 2002. Pharmacokinetic interactions between warfarin and kangen-karyu, a Chinese traditional herbal medicine, and their synergistic action. J Ethnopharmacol. 82:35–40.
   PubMed Web of Science ®Google Scholar
• Marcatto LR, Sacilotto L, Darrieux FC, Hachul DT, Scanavacca MI, Krieger JE, Pereira AC, Santos PC. 2016. Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation. Oncotarget. 7(34):54194–54199.
   PubMedGoogle Scholar
• Mitchell AA. 1972. Smoking and warfarin dosage. N Engl J Med. 287:1153–1154.
   PubMed Web of Science ®Google Scholar
• Miyagata Y, Nakai K, Sugiyama Y. 2011. Clinical significance of combined CYP2C9 and VKORC1 genotypes in Japanese patients requiring warfarin. Int Heart J. 52(1):44–49.
   PubMed Web of Science ®Google Scholar
• Mohammed Abdul MI, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, McLachlan AJ. 2008. Pharmacodynamic interaction of warfarin with cranberry but not with garlic in healthy subjects. Br J Pharmacol. 154:1691–1700.
   PubMed Web of Science ®Google Scholar
• Mushiroda T, Ohnishi Y, Saito S, Takahashi A, Kikuchi Y, Saito S, Shimomura H, Wanibuchi Y, Suzuki T, Kamatani N, et al. 2006. Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients. J Hum Genet. 51:249–253.
   PubMed Web of Science ®Google Scholar
• Nathisuwan S, Dilokthornsakul P, Chaiyakunapruk N, Morarai T, Yodting T, Piriyachananusorn N. 2011. Assessing evidence of interaction between smoking and warfarin: a systematic review and meta-analysis. Chest. 139(5):1130–1139.
   PubMed Web of Science ®Google Scholar
• Obayashi K, Nakamura K, Kawana J, Ogata H, Hanada K, Kurabayashi M, Hasegawa A, Yamamoto K, Horiuchi R. 2006. VKORC1 gene variations are the major contributors of variation in warfarin dose in Japanese patients. Clin Pharmacol Ther. 80(2):169–178.
   PubMed Web of Science ®Google Scholar
• Ovesen L, Lyduch S, Idorn ML. 1988. The effect of a diet rich in brussels sprouts on warfarin pharmacokinetics. Eur J Clin Pharmacol. 34:521–523.
   PubMed Web of Science ®Google Scholar
• Panossian A, Hovhannisyan A, Abrahamyan H, Gabrielyan E, Wikman G. 2009. Pharmacokinetic and pharmacodynamic study of interaction of Rhodiola rosea SHR-5 extract with warfarin and theophylline in rats. Phytother Res. 23:351–357.
   PubMed Web of Science ®Google Scholar
• Ramanathan MR, Penzak SR. 2017. Pharmacokinetic drug interactions with Panax ginseng. Eur J Drug Metab Pharmacokinet. 42:545–557.
   PubMed Web of Science ®Google Scholar
• Rasmussen MA, Skov J, Bladbjerg EM, Sidelmann JJ, Vamosi M, Jespersen J. 2012. Multivariate analysis of the relation between diet and warfarin dose. Eur J Clin Pharmacol. 68:321–328.
   PubMed Web of Science ®Google Scholar
• Rukayadi Y, Hwang JK. 2013. In vitro activity of xanthorrhizol isolated from the rhizome of Javanese turmeric (Curcuma xanthorrhiza Roxb.) against Candida albicans biofilms. Phytother Res. 27:1061–1066.
   PubMed Web of Science ®Google Scholar
• Rusdiana T, Araki T, Nakamura T, Subarnas A, Yamamoto K. 2013. Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population. Eur J Clin Pharmacol. 69(3):395–405.
   PubMed Web of Science ®Google Scholar
• Salleh NA, Ismail S, Ab Halim MR. 2016. Effects of Curcuma xanthorrhiza extracts and their constituents on phase II drug-metabolizing enzymes activity. Pharmacog Res. 8:309–315.
   PubMed Web of Science ®Google Scholar
• Sasaki T, Tsuda S, Trujillo M, Kirk Riemer R, Reinhartz O. 2012. Maintenance dose of warfarin in sheep and effect of diet: a preliminary report. J Invest Surg. 25(1):29–32.
   PubMed Web of Science ®Google Scholar
• Shen C, Huang X, Li J, Zhang P, Li L, Zhang W, Hu T, Pappoe F, Huang J, Tang H. 2016. Pharmacokinetic and pharmacodynamic interactions of aspirin with warfarin in beagle dogs. Xenobiotica. 46:530–541.
   PubMed Web of Science ®Google Scholar
• Tanaka KD, Kawai YK, Ikenaka Y, Harunari T, Tanikawa T, Fujita S, Ishizuka M. 2013. A novel mutation in VKORC1 and its effect on enzymatic activity in Japanese warfarin-resistant rats. J Vet Med Sci. 75(2):135–139.
   PubMed Web of Science ®Google Scholar
• Ueng YF, Lu CK, Yang SH, Wang HJ, Huang CC. 2017. Potentiation of the anticoagulation effect of warfarin by the herbal remedy Shu-Jing-Hwo-Shiee-Tang in rats: the dosing regimen and pharmacokinetic interaction. Drug Metab Pharmacokinet. 32(1):85–91.
   PubMed Web of Science ®Google Scholar
• Volak LP, Ghirmai S, Cashman JR, Court MH. 2008. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor. Drug Metab Dispos. 36:1594–1605.
   PubMed Web of Science ®Google Scholar
• Vranckx P, Valgimigli M, Heidbuchel H. 2018. The significance of drug-drug and drug-food interactions of oral anticoagulation. Arrhythm Electrophysiol Rev. 7(1):55–61.
   PubMed Web of Science ®Google Scholar
• Wakamiya T, Hokosaki T, Tsujimoto S, Kadota K, Nakano Y, Watanabe S, Iwamoto M, Yanagimachi M, Ito S. 2016. Effect of VKORC1, CYP2C9, CFP4F2, and GGCX gene polymorphisms on warfarin dose in Japanese pediatric patients. Mol Diagn Ther. 20:393–400.
   PubMed Web of Science ®Google Scholar
• Werba JP, Misaka S, Giroli MG, Shimomura K, Amato M, Simonelli N, Vigo L, Tremoli E. 2018. Update of green tea interactions with cardiovascular drugs and putative mechanisms. J Food Drug Anal. 26(2S):S72–S77.
   PubMedGoogle Scholar
• Widyowati R, Agil M. 2018. Chemical constituents and bioactivities of several Indonesian plants typically used in Jamu. Chem Pharm Bull. 66:506–518.
   PubMed Web of Science ®Google Scholar
• Yan JH, Meyers D, Lee Z, Danis K, Neelakantham S, Majumdar T, Rebello S, Sunkara G, Chen J. 2014. Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin. J Clin Pharmacol. 54:800–808.
   PubMed Web of Science ®Google Scholar
• Yoo SH, Nah HW, Jo MW, Kang DW, Kim JS, Koh JY, Kwon SU. 2009. Age and body weight adjusted warfarin initiation program for ischaemic stroke patients. Eur J Neurol. 16(10):1100–1105.
   PubMed Web of Science ®Google Scholar
• Yoshizawa M, Hayashi H, Tashiro Y, Sakawa S, Moriwaki H, Akimoto T, Doi O, Kimura M, Kawarasaki Y, Inoue K, et al. 2009. Effect of VKORC1-1639 G > A polymorphism, body weight, age, and serum albumin alterations on warfarin response in Japanese patients. Thromb Res. 124:161–166.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang X, Wang X, Zhao M. 2018. Influence of andrographolide on the pharmacokinetics of warfarin in rats. Pharm Biol. 56(1):351–356.
   PubMed Web of Science ®Google Scholar
• Zhao HF, Sun JH, Liu S, Liu Y, Liu GF. 2017. [ Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats. ]. Zhongguo Zhong Yao Za Zhi. 42(5):982–988.
   PubMedGoogle Scholar
• Zhou L, Wang S, Zhang Z, Lau BS, Fung KP, Leung PC, Zuo Z. 2012. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin. J Ethnopharmacol. 143(2):648–655.
   PubMed Web of Science ®Google Scholar
• Zhu M, Chan KW, Ng LS, Chang Q, Chang S, Li RC. 1999. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol. 51:175–180.
   PubMed Web of Science ®Google Scholar